Analyst Ratings for Reneo Pharmaceuticals (RPHM)
RPHM Rating Summary
RPHM Price Target Summary
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$6.56 (+270.6%)
* Over Last 12-Mos
Rating Score: 1.3 / 10
Percentile Rank: 9%
Avg. $ Target:
$6.56 (+270.6%)
* Over Last 12-Mos
Rating Score: 1.3 / 10
Percentile Rank: 9%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/15/2023 | H.C. Wainwright | Mitchell Kapoor | Downgrade | Neutral (Buy) |
N/A (N/A) |
1.34 (1.77) |
32.09% | Details |
| 12/15/2023 | Leerink Partners | Joseph P. Schwartz | Downgrade | Market Perform (Outperform) |
1.00 (15.00) |
7.75 (1.77) |
-77.16% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
